Mutual Exclusivity of Hyaluronan and Hyaluronidase in Invasive Group A Streptococcus*

Background: Serotype M4 group A Streptococcus lack hyaluronic acid (HA) capsule, but are capable of causing human disease. Results: Encapsulation was achieved by introducing the hasABC capsule synthesis operon in the absence of HA-degrading enzyme hyaluronate lyase (HylA). Conclusion: Capsule expression does not enhance M4 GAS virulence. Significance: We demonstrate a mutually exclusive interaction between GAS capsule and HylA expression. A recent analysis of group A Streptococcus (GAS) invasive infections in Australia has shown a predominance of M4 GAS, a serotype recently reported to lack the antiphagocytic hyaluronic acid (HA) capsule. Here, we use molecular genetics and bioinformatics techniques to characterize 17 clinical M4 isolates associated with invasive disease in children during this recent epidemiology. All M4 isolates lacked HA capsule, and whole genome sequence analysis of two isolates revealed the complete absence of the hasABC capsule biosynthesis operon. Conversely, M4 isolates possess a functional HA-degrading hyaluronate lyase (HylA) enzyme that is rendered nonfunctional in other GAS through a point mutation. Transformation with a plasmid expressing hasABC restored partial encapsulation in wild-type (WT) M4 GAS, and full encapsulation in an isogenic M4 mutant lacking HylA. However, partial encapsulation reduced binding to human complement regulatory protein C4BP, did not enhance survival in whole human blood, and did not increase virulence of WT M4 GAS in a mouse model of systemic infection. Bioinformatics analysis found no hasABC homologs in closely related species, suggesting that this operon was a recent acquisition. These data showcase a mutually exclusive interaction of HA capsule and active HylA among strains of this leading human pathogen.

[1]  A. Steer,et al.  Severe group A streptococcal infections in a paediatric intensive care unit , 2014, Journal of paediatrics and child health.

[2]  Xueping Guo,et al.  A Novel Hyaluronidase Produced by Bacillus sp. A50 , 2014, PloS one.

[3]  I. de Filippis,et al.  Haemophilus influenzae serotype b and a capsule-deficient type mutant (b-) invasive disease in a partially vaccinated child in Brazil. , 2013, Journal of medical microbiology.

[4]  V. Nizet,et al.  Study of streptococcal hemoprotein receptor (Shr) in iron acquisition and virulence of M1T1 group A streptococcus , 2012, Virulence.

[5]  J. Musser,et al.  Human Disease Isolates of Serotype M4 and M22 Group A Streptococcus Lack Genes Required for Hyaluronic Acid Capsule Biosynthesis , 2012, mBio.

[6]  Dwight R. Johnson,et al.  Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  A. Blom,et al.  Enolase of Streptococcus pneumoniae Binds Human Complement Inhibitor C4b-Binding Protein and Contributes to Complement Evasion , 2012, The Journal of Immunology.

[8]  V. Nizet,et al.  A Conserved UDP-Glucose Dehydrogenase Encoded outside the hasABC Operon Contributes to Capsule Biogenesis in Group A Streptococcus , 2012, Journal of bacteriology.

[9]  J. Nyalwidhe,et al.  Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. , 2012, Molecular immunology.

[10]  G. Alfarone,et al.  Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  V. Nizet,et al.  Molecular insight into invasive group A streptococcal disease , 2011, Nature Reviews Microbiology.

[12]  John E. Johnson,et al.  Streptococcal M1 protein constructs a pathological host fibrinogen network , 2011, Nature.

[13]  V. Nizet,et al.  Streptococcal Inhibitor of Complement Promotes Innate Immune Resistance Phenotypes of Invasive M1T1 Group A Streptococcus , 2010, Journal of Innate Immunity.

[14]  V. Nizet,et al.  M Protein and Hyaluronic Acid Capsule Are Essential for In Vivo Selection of covRS Mutations Characteristic of Invasive Serotype M1T1 Group A Streptococcus , 2010, mBio.

[15]  H. Smith,et al.  Invasive group A streptococcal disease in children in Queensland , 2010, Epidemiology and Infection.

[16]  V. Nizet,et al.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. , 2010, The Journal of infectious diseases.

[17]  Haruo Watanabe,et al.  Highly Frequent Mutations in Negative Regulators of Multiple Virulence Genes in Group A Streptococcal Toxic Shock Syndrome Isolates , 2010, PLoS pathogens.

[18]  W. Hynes,et al.  A single nucleotide mutation results in loss of enzymatic activity in the hyaluronate lyase gene of Streptococcus pyogenes. , 2009, Microbial pathogenesis.

[19]  J. Carapetis,et al.  Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. , 2009, The Lancet. Infectious diseases.

[20]  I. Margarit,et al.  Capturing host‐pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  V. Nizet,et al.  A Naturally Occurring Mutation in ropB Suppresses SpeB Expression and Reduces M1T1 Group A Streptococcal Systemic Virulence , 2008, PloS one.

[22]  S. Rodríguez de Córdoba,et al.  Binding of complement regulatory proteins to group A Streptococcus. , 2008, Vaccine.

[23]  A. Blom,et al.  Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae. , 2008, Vaccine.

[24]  G. Stollerman,et al.  The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Malak Kotb,et al.  DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection , 2007, Nature Medicine.

[26]  M. Dowton,et al.  The Plasminogen-Binding Group A Streptococcal M Protein-Related Protein Prp Binds Plasminogen via Arginine and Histidine Residues , 2006, Journal of bacteriology.

[27]  V. Nizet,et al.  Trigger for group A streptococcal M1T1 invasive disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Michal J. Nagiec,et al.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Lindahl,et al.  Extreme Sequence Divergence but Conserved Ligand-Binding Specificity in Streptococcus pyogenes M Protein , 2006, PLoS pathogens.

[30]  G. Ball,et al.  Human C4b-binding Protein, Structural Basis for Interaction with Streptococcal M Protein, a Major Bacterial Virulence Factor* , 2006, Journal of Biological Chemistry.

[31]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[32]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[33]  J. Musser,et al.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.

[34]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[35]  G. Lindahl,et al.  Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway , 2005, Molecular microbiology.

[36]  L. Hoang,et al.  Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  M. Dowton,et al.  Two Distinct Genotypes of prtF2, Encoding a Fibronectin Binding Protein, and Evolution of the Gene Family in Streptococcus pyogenes , 2004, Journal of bacteriology.

[38]  K. Berggård,et al.  Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein , 2003, The Journal of experimental medicine.

[39]  J. Baker,et al.  The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. , 2002, The Biochemical journal.

[40]  D. Bessen,et al.  Genomic Localization of a T Serotype Locus to a Recombinatorial Zone Encoding Extracellular Matrix-Binding Proteins in Streptococcus pyogenes , 2002, Infection and Immunity.

[41]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Hanski,et al.  Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. , 2000, The Journal of infectious diseases.

[43]  Malak Kotb,et al.  Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases , 2000, Infection and Immunity.

[44]  I. Stamenkovic,et al.  CD44 as a receptor for colonization of the pharynx by group A Streptococcus. , 2000, The Journal of clinical investigation.

[45]  R. Kennedy,et al.  Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection , 2000, Cellular microbiology.

[46]  A. Blom,et al.  Human C4b-Binding Protein Has Overlapping, But Not Identical, Binding Sites for C4b and Streptococcal M Proteins1 , 2000, The Journal of Immunology.

[47]  A. Dixon,et al.  The extracellular hyaluronidase gene (hylA) of Streptococcus pyogenes. , 2000, FEMS microbiology letters.

[48]  J. Benach,et al.  Use of the plasminogen activation system by microorganisms. , 1999, The Journal of laboratory and clinical medicine.

[49]  Dwight R. Johnson,et al.  emm typing and validation of provisional M types for group A streptococci. , 1999, Emerging infectious diseases.

[50]  V. Fischetti,et al.  α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci* , 1998, The Journal of Biological Chemistry.

[51]  M. Wessels,et al.  Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. , 1998, The Journal of clinical investigation.

[52]  H. Courtney,et al.  Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells , 1997, Infection and immunity.

[53]  M. Wessels,et al.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.

[54]  M. Wessels,et al.  Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci , 1996, Infection and immunity.

[55]  M. Boyle,et al.  Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. , 1995, Microbial pathogenesis.

[56]  M. Wessels,et al.  Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Coligan,et al.  Cloning and expression of the gene for group B streptococcal hyaluronate lyase. , 1994, The Journal of biological chemistry.

[58]  J. Goldberg,et al.  Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci , 1994, Infection and immunity.

[59]  U. Sjöbring,et al.  PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. , 1993, The Journal of biological chemistry.

[60]  P. Weigel,et al.  Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. , 1993, The Journal of biological chemistry.

[61]  M. Leippe,et al.  Role of fibrinogen in complement inhibition by streptococcal M protein , 1992, Infection and immunity.

[62]  C. Ponting,et al.  Plasminogen: a structural review. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[63]  V. Fischetti,et al.  A major surface protein on group A streptococci is a glyceraldehyde-3- phosphate-dehydrogenase with multiple binding activity , 1992, The Journal of experimental medicine.

[64]  B. Dougherty,et al.  Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci , 1992, The Journal of experimental medicine.

[65]  J. Goldberg,et al.  Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Marcum,et al.  Species specificity of streptokinase. , 1983, Comparative biochemistry and physiology. B, Comparative biochemistry.

[67]  W. Wood,et al.  STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI , 1959, The Journal of experimental medicine.

[68]  W. Wood,et al.  STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI , 1959, The Journal of experimental medicine.

[69]  A. Maclennan.  The production of capsules, hyaluronic acid and hyaluronidase by 25 strains of group C streptococci. , 1956, Journal of general microbiology.

[70]  A. Maclennan.  The production of capsules, hyaluronic acid and hyaluronidase by group A and group C streptococci. , 1956, Journal of general microbiology.

[71]  V. Faber,et al.  Streptococcal hyaluronidase. II. Studies on the production of hyaluronidase and hyaluronic acid by representatives of all types of hemolytic streptococci belonging to group A. , 2009, Acta pathologica et microbiologica Scandinavica.